The aim of the Lexicon is to describe the functions which define integrated behavioral health in primary care practices to clarify what to implement and what to expect.
This case study explores implementation of medications for opioid use disorder (MOUD) through a partnership between a Missouri-based federally qualified health center (FQHC) and Certified Community Behavioral Health Clinic (CCBHC).
This report provides an update on the present state of coverage, availability of, and access to, medications for treating ongoing alcohol use disorder and opioid use disorder, and reversing an opioid overdose within state Medicaid plans.
This Topic Brief provides an overview of what constitutes low-threshold treatment for patients with OUD, the state of the evidence and patient perspectives on low-threshold OUD treatment, and key steps and strategies for providing low-threshold treatment for patients with OUD in primary care settings.
This Topic Brief represents a brief overview of the available research on addressing polysubstance use in a primary care setting with a focus on leveraging an integrated behavioral health team.
This Topic Brief discusses perinatal behavioral health conditions, which include mental health and substance use disorders during pregnancy and the postpartum period (up to 12 months after delivery).
This Topic Brief provides an overview of the state of the evidence for behavioral health apps and key considerations and concerns related to finding, evaluating, and selecting smartphone and Internet-based behavioral health apps to recommend or prescribe in primary care and integrated care settings.
This Topic Brief covers foundational information on disparities in health and healthcare (including in substance use disorder), the role of behavioral health integration in reducing disparities, and ensuring advancement of health equity within integrated care settings.
This Topic Brief provides information on the impact of the COVID-19 pandemic on the behavioral health of the general public and healthcare workers, the impact of substance use disorders on COVID-19 outcomes, and other topics.